Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)

AIM: Evaluate long-term real-world treatment patterns and associated effectiveness and safety outcomes in patients with diabetic macular edema (DME) treated ≥36 months with 0.5mg ranibizumab. METHODS: Open-label observational effectiveness study in 9 Belgian clinics. Included were primary treated ey...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Aken, Elisabeth, Favreau, Mérédis, Ramboer, Eva, Denhaerynck, Kris, MacDonald, Karen, Abraham, Ivo, Brié, Heidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720424/
https://www.ncbi.nlm.nih.gov/pubmed/33299294
http://dx.doi.org/10.2147/OPTH.S281501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720424/
https://www.ncbi.nlm.nih.gov/pubmed/33299294
http://dx.doi.org/10.2147/OPTH.S281501

Ejemplares similares